• Population Access to Rotavirus Vaccination in Industrialized Countries- Lessons Learnt from Current Experience

    Nov 1, 2014, 00:00

  • Trend in Prevalence and Distribution of Diabetes Mellitus Type I and Type II in the Netherlands

    Nov 1, 2014, 00:00

  • Cost and Quantity Characteristics of Medical Devices In Slovakia

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination Program

    Nov 1, 2014, 00:00

  • The Risk of Metabolic Disorders in Patients Treated with Asenapine or Olanzapine- A Real World Data Study Conducted in Italy and Spain

    Nov 1, 2014, 00:00

  • New Meta-Analysis of Patient-Level Data on Efficacy And Hypoglycaemia with Insulin Glargine or Nph Insulin in Type 2 Diabetes Mellitus (T2DM) According to Concomitant Oral Therapy

    Nov 1, 2014, 00:00

  • Towards Universal Health Care- A Review of the Basic Basket of Care Associated With Universal Health Care Delivery Models

    Nov 1, 2014, 00:00

  • Monitoring Antiretroviral Therapy in Uganda- Budget Impact Analysis of Two Strategies for Viral Load Monitoring Versus Immunologic Monitoring

    Nov 1, 2014, 00:00

  • Economic Impact of Clinical Researches to the Research Centers and Reimbursement Systems in Turkey

    Nov 1, 2014, 00:00

  • Medium Term Avoided Costs- High-Dose Hypoallergenic House Dust Mite Preparation Immunotherapy Verse Conventional Symptomatic Treatment

    Nov 1, 2014, 00:00

  • Impact of Pharmacoeconomics Guidelines on the International Publications in China

    Nov 1, 2014, 00:00

  • Redel Study- Differences in Reimbursement Delays in Cee Countries

    Nov 1, 2014, 00:00

  • Patients' Preferences for Bone Metastases Treatments in Turkey

    Nov 1, 2014, 00:00

  • Fixed Dose Combinations of Nucleoside Reverse Transcriptase Inhibitor for Naïve Patient with Hiv Infection in Russia- Cost Comparison Analysis

    Nov 1, 2014, 00:00

  • Policy Evaluation of Anti-Hypertensive Drugs in Mumbai, India

    Nov 1, 2014, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead To Systematic Damage Of Ireland's Health System?

    Nov 1, 2014, 00:00

  • Economic Evaluation of Catheter-Based Renal Denervation for Patients with Resistant Hypertension in Korea

    Nov 1, 2014, 00:00

  • Health Related Quality of Life and Patient Satisfaction in Colorectal Cancer Patients Treated Through Radical Surgery in Curative Intent in a Colo-Proctology Clinical Department

    Nov 1, 2014, 00:00

  • Database Analysis On Patients Using Immunobiological Drugs In A Brazilian Private Health Care Plan- A Real World Data Analysis

    Nov 1, 2014, 00:00

  • Restless Leg Syndrome Detection in Hemodialysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer

    Nov 1, 2014, 00:00

  • Non-Treatment Specific Parameter Value Estimates- Relationship Between BMI and Utility

    Nov 1, 2014, 00:00

  • Individualised Growth Response Optimisation (IGRO)- A Multi-Language Software Medical Device to Predict Growth Response in Children Treated With Growth Hormone (GH)

    Nov 1, 2014, 00:00

  • Testing The Utility Of The Nhs's Systemic Anti-Cancer Therapy Data Set For Multi-Indication Pricing

    Nov 1, 2014, 00:00

  • Prescribing Patterns and Treatment Outcomes in North Indian Female Patients with Chronic Low Back Pain

    Nov 1, 2014, 00:00

  • Predictive Modelling for Optimal Target Population and Real-World Study Design- An Example In Mother-To-Child Transmission of HIV

    Nov 1, 2014, 00:00

  • Evaluating The Long-Term Cost-Effectiveness Of Liraglutide 1.2 Mg And Exenatide In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Health Care Costs and Utilization of U. S. Veteran Patients Diagnosed with Pancreatic Cancer

    Nov 1, 2014, 00:00

  • Clinical Research for the Effectiveness and Economic Value of Qinxitong in the Patients with Ra in China

    Nov 1, 2014, 00:00

  • General Beliefs About Medicines Among Depressed Patients in Saudi Arabia

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of Treatment for Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) in France

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of the Use of Crizotinib for Non-Small Cell Lung Cancer and ALK+ Mutation in the Two Main Public Health Care Institutions in Mexico

    Nov 1, 2014, 00:00

  • Social Aspects of HCV Treatment In Kazakhstan

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of EGFR-TK Mutation Status-Guided 1st- and 2nd-Line Treatment of Stage III/IV Non-Small Cell Lung Cancer in the UK

    Nov 1, 2014, 00:00

  • Cost Consequence Model Investigating the Impact of Bowel Cleansing on Prevention of Colorectal Cancer in a German Screening Population

    Nov 1, 2014, 00:00

  • Pollen Morphology and Total Protein of Taraxacum Officinale and Aster Alpinus

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation and Burden of Illness of Acute Exacerbation of Copd in Patients in Malaysia

    Nov 1, 2014, 00:00

  • Subjective Expectations Regarding Life Expectancy And Health-Related Quality Of Life In Moderate To Severe Psoriasis Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Capsaicin 8% Patch (Qutenzatm) Compared With Pregabalin for the Treatment of Patients With Peripheral Neuropathic Pain (Pnp) In Scotland

    Nov 1, 2014, 00:00

  • A Quantification of Expenditure on Hospital Stays In 5 European Countries

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Strontium Ranelate Verse Alendronate for Management of Osteoporosis Among Post-Menopausal Women in Malaysia Using A Markov Modelling Approach

    Nov 1, 2014, 00:00

  • Claims Reimbursement Analysis of the National Health Insurance Scheme in Ghana

    Nov 1, 2014, 00:00

  • Expanded Data Sets For Hta Decision-Making In Oncology- Do They Help To Achieve Positive Appraisals?

    Nov 1, 2014, 00:00

  • A Reliability Generalisation of the Eortc Qlq-Br23

    Nov 1, 2014, 00:00

  • Examination of the Efficiency of Electrical Stimulation in Case of Stress and Urge Incontinence

    Nov 1, 2014, 00:00

  • The Influence Of Gene Expression Profiling (GEP) On Decisional Conflict In Chemotherapy Treatment Decision-Making For Early-Stage Breast Cancer (BRCA)

    Nov 1, 2014, 00:00

  • Medical Expenditure For People With Diabetes In Urban Employee Basic Medical Insurance For Hebei Provincial Institutes

    Nov 1, 2014, 00:00

  • A Review Of Cost Of Illness Studies In Patients With End Stage Renal Disease

    Nov 1, 2014, 00:00

  • Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia

    Nov 1, 2014, 00:00

  • Impact of Copayment Reduction or Exemption Programme on Generic Drug Utilisation- the Specified Disease Treatment Research Programme in Japan

    Nov 1, 2014, 00:00

  • Investigating the Impact of Perspective on Weighting Qalys- a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • The Economic Burden of Systemic Lupus Erythematosus- A Structured Literature Review

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France

    Nov 1, 2014, 00:00

  • Pregnancy Outcomes in Women with Inflammatory Bowel Syndrome Following Exposure to Thiopurines and Anti-Tumor Necrosis Factor Drugs- A Meta-Analysis and Systematic Review

    Nov 1, 2014, 00:00

  • Prescribing Pattern of Anti-Emetics for Prevention of Chemotherapy Induced Nausea Vomiting—An Observation of Clinical Practice Versus Standard Guidelines

    Nov 1, 2014, 00:00

  • Economic Assessment of Preeclampsia- Screening, Diagnosis, Treatment Options, and Long Term Outcomes, A Systematic Review

    Nov 1, 2014, 00:00

  • Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab In Patients With Follicular Lymphoma Responding To First Line Induction Therapy In Portugal

    Nov 1, 2014, 00:00

  • Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle- A Systematic Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Saxagliptin Compared To Glp-1 Analogues As An Add-On To Insulin in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Radical Prostatectomy, Radiation Therapy and Active Surveillance for the Treatment of Localized Prostate Cancer – A Claims Data Analysis

    Nov 1, 2014, 00:00

  • Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia

    Nov 1, 2014, 00:00

  • COST-EFFECTIVENESS OF POST-THERAPY PET AND TELEPHONE INTERVIEW IN THE CLINICAL FOLLOW-UP OF PATIENTS TREATED WITH LOCALLY ADVANCED CERVICAL CANCER

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Grounding Of Using Polypill Amlodipine With Atorvastatin Versus Monodrugs In Patients With Hypertension And Dyslipidemia In Ukraine

    Nov 1, 2014, 00:00

  • Efficacy, Effectiveness and the “Efficacy-To-Effectiveness Gap”- Review of the Current State of Play and Perspectives. First Results From the Imi Getreal Consortium

    Nov 1, 2014, 00:00

  • The Importance of Sensitivity Analysis in Assessing Clinical and Economic Impact of National Immunization Programs- An Example of Slovenia

    Nov 1, 2014, 00:00

  • Comparison of the Valuation of Treatment Alternatives in Parkinson's Disease with Best-Worst Scaling, Time Trade-off and Visual Analogue Scales

    Nov 1, 2014, 00:00

  • The Relationship Between Macular Edema and Health Outcomes Among Patients With Diabetes in Western Europe

    Nov 1, 2014, 00:00

  • The Burden of Non-Small Cells Lung Cancer (NSCLC) in First Line (1L) Treatment- Patterns of Care and Cost of Illness

    Nov 1, 2014, 00:00

  • Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database

    Nov 1, 2014, 00:00

  • A Comparison of Value for Health States Worse Than Dead Between Japan and Uk

    Nov 1, 2014, 00:00

  • Long-Term Grading of Health-Related Quality of Life of Care-Needed Elderly- A 2-Yr Follow-Up Study

    Nov 1, 2014, 00:00

  • Comparison of Resource use and Health Care Costs in New Initiators of Long-Acting Injectable (Lai) and Oral Second Generation Antipsychotics

    Nov 1, 2014, 00:00

  • Do HTA Processes Correlate With Reimbursement Recommendations?

    Nov 1, 2014, 00:00

  • Early Retirement Indirect Costs Attributable to Rheumatic Diseases in Portugal

    Nov 1, 2014, 00:00

  • Development Of A Global Economic Model To Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment

    Nov 1, 2014, 00:00

  • Example of Analysis Utilizing Real World Data- Medical Cost Reduction by Advising Untreated-Hypertension Patients to Visit Doctors

    Nov 1, 2014, 00:00

  • The Impact of Disease Modification on the Cost-Effectiveness of Pegloticase for the Treatment of Severe Debilitating Chronic Tophaceous Gout In Adult Patients

    Nov 1, 2014, 00:00

  • A Real-World Characterization of Patients With “Moderate-To-Severe” Systemic Lupus Erythematosus

    Nov 1, 2014, 00:00

  • A Comparison of Three Language Versions of the EQ-5D-5L Dimension Scales in Singapore

    Nov 1, 2014, 00:00

  • An Archetype For Classification and Comparison of Hta Activities in Latin America

    Nov 1, 2014, 00:00

  • Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceutical ...

    Nov 1, 2014, 00:00

  • Assessment of Utilities in Japan- Data Availability and Methodology

    Nov 1, 2014, 00:00

  • Interventions and Policy Measures in Health Care And Pharmaceutical Sector To Increase Effeciency And Recovery of Greek Health Care System

    Nov 1, 2014, 00:00

  • An Examination of the Regulatory and Reimbursement Processes for Biobetters and Comparison With Biosimilars

    Nov 1, 2014, 00:00

  • An Analysis Of The Utilization Of Cephalosporins From 2007 To 2011 In Guangdong Province Of China

    Nov 1, 2014, 00:00

  • Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)

    Nov 1, 2014, 00:00

  • Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis – A Case Study in Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Acceptance Of Telemonitoring By Health Care Professionals in Germany- A Question Of Financial Conditions

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Drugs for Ultra-Rare Non-Oncological Diseases In Europe

    Nov 1, 2014, 00:00

  • What The English Could Learn From The Irish- Making The Nice Approval Process More Cost-Effective

    Nov 1, 2014, 00:00

  • Prevalence Of Symptoms And Cluster Analysis In Dialysis Patients Using Kdqol-36

    Nov 1, 2014, 00:00

  • A Spanish Cost-Effectiveness Analysis Of Sevelamer Versus Calcium Carbonate In Nondialysis-Dependent Chronic Kidney Disease (Ckd) Patients

    Nov 1, 2014, 00:00

  • Disease Burden of Unintended Pregnancy in China

    Nov 1, 2014, 00:00

  • Simulating Individual Patient Level Data To Address Treatment Switching When Only Summary Data Are Available

    Nov 1, 2014, 00:00

  • Evaluation of Estimators of Treatment Effect in Observational Studies

    Nov 1, 2014, 00:00

  • Aging Impact Over the National Health Cost in Extremadura Public Health Expenditure of Extremadura in the Period 2011-21

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Real-Time Medication Monitoring in Children with Asthma

    Nov 1, 2014, 00:00

  • C5a Receptor Antagonist Protects Mice from Uropathogenic Escherichia Coli-Induced Kidney Infection

    Nov 1, 2014, 00:00

  • Prescription Practices for Uncomplicated Malaria at two Public Health Facilities in Nigeria; A Descriptive, Comparative Study

    Nov 1, 2014, 00:00

  • Effects of A Multidisciplinary Home-Based Medication Review Program On Hospital Admissions In Older Adult Singaporeans

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey

    Nov 1, 2014, 00:00

  • Long Term Follow up of Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients- “Real-World” Data from the Island of Crete

    Nov 1, 2014, 00:00

  • The Use of Integrated Concept Mapping to Develop the Dementia Care Model by Community Participation

    Nov 1, 2014, 00:00

  • Clinical and Cost-Effectiveness and Budget Impact of Routine Use of Bispectral Index Monitors In Theatres

    Nov 1, 2014, 00:00

  • Significant and Meaningful Improvement in Treatment Satisfaction with Teriflunomide Versus Subcutaneous IFNB-1A in Patients with Relapsing MS Results from Tenere

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Certolizumab Pegol in the Management of Patients With Moderate-To-Severe Active Rheumatoid Arthritis in Greece

    Nov 1, 2014, 00:00

  • Potential Monetary Value of Human Papillomavirus Vaccination on Human Papillomavirus-Related Cancers and Genital Warts in the United Kingdom

    Nov 1, 2014, 00:00

  • Orphan Drug Approvals In Europe- Historical Review and Trends

    Nov 1, 2014, 00:00

  • The Burden Of Primary Hyperhidrosis On The Patient- Eq-5d-5l Utilities, Willingness To Pay And Daily Time Spent In Managing The Condition

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Human Insulin Versus Animal Insulin Among Patients with Diabetes in China- A Meta-Analysis

    Nov 1, 2014, 00:00

  • The Budget Impact of Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbohaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in the United Kingdom- Impact on Health Care Co ...

    Nov 1, 2014, 00:00

  • The Effects of Gallium Chloride on Apoptosis Osteoporosis Model of Rats Caused by Tretinoin Acid

    Nov 1, 2014, 00:00

  • A Cost Utility Analysis of Amlodipine Compared with Angiotensin II Receptor Blockers in Preventing Stroke and Myocardial Infarction Among Hypertension Patients in the Philippines

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Palivizumab Use in High Risk Children From Brazilian Health System Perspective

    Nov 1, 2014, 00:00

  • Prevalence of Febrile Neutropenia in Breast Cancer Patients Received Adjuvant Paclitaxel Treatment

    Nov 1, 2014, 00:00

  • Assessment of Need, Development and Implementation of Supportive Management Database for the Treatment of Poisoning Cases in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Evaluating the Translatability of Physical Assessment Clinical Outcomes Assessment (Coa) Items

    Nov 1, 2014, 00:00

  • Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in Belgium

    Nov 1, 2014, 00:00

  • Closing the Gap- Reduced Delay to Drug Marketing Approval Between The West and Asia

    Nov 1, 2014, 00:00

  • All-Cause Mortality Validation of the Core Diabetes Model Against Predictions of the Charlson Comorbidity Index

    Nov 1, 2014, 00:00

  • ECOA Licensing- Lessons Learned from the Copyright of COA Translations and Specificities of ECOAS

    Nov 1, 2014, 00:00

  • Discontinuities Between Health Technology Assessment (HTA) and Health Care Service Objectives of the NHS

    Nov 1, 2014, 00:00

  • Time to Reimbursement for Oncology Agents from EMA Marketing Authorization to AIFA Approval AS “C(NN)” Class versus. AIFA Approval AS “A” or “H” Class

    Nov 1, 2014, 00:00

  • Factors Conditioning Health Related Quality Of Life In Patients With Psoriasis In Europe- A Systematic Review Of The Literature

    Nov 1, 2014, 00:00

  • Patients' Preferences in Oral Diabetes Treatment- A Discrete Choice Experiment in Type2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • A Double-Blind Controlled Study of the Efficacy and Safety of Long-Acting Amfepramone Treatment In Mexican Obese Patients

    Nov 1, 2014, 00:00

  • Access to Asthma Medicines in Tehran; Iran

    Nov 1, 2014, 00:00

  • Exploring Uncertainty in Economic Evaluation Of Medicines- A Review of The First Manufacturers' Submissions To the French National Authority For Health (Has)

    Nov 1, 2014, 00:00

  • The Possibility of Initiating True Risk-Sharing Agreements in the Current Economic Situation

    Nov 1, 2014, 00:00

  • Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs

    Nov 1, 2014, 00:00

  • Health Economics Evaluation for Insulin Injection Pen-Needle with Different Lengths in Patients With Diabetes in China

    Nov 1, 2014, 00:00

  • Direct Costs of Treatment of Skin Drug Reactions Induced by Antibiotics in Perspective of Public Payer and Service Provider

    Nov 1, 2014, 00:00

  • The Performance of the Pragmatic Strategy to Bring in Pharmacoeconomic Evidence for Drugs Reimbursement Decisions in Taiwan

    Nov 1, 2014, 00:00

  • The Humanistic and Economic Burden of Partial Onset Seizures in the Europe Five and Brazil Using a Patient Survey

    Nov 1, 2014, 00:00

  • Prevalence of Neuropathic Pain and Its Disease Burden In Korea Patients With Lumbar Spine Surgery

    Nov 1, 2014, 00:00

  • The Dynamics Of Prices And Quantities Of New Drugs Under Taiwan's National Health Insurance Program

    Nov 1, 2014, 00:00

  • The Costs of Diagnosis and Treatment of Ankle Sprains and Fractures, 1980-2013- A Systematic Review

    Nov 1, 2014, 00:00

  • Modeling to Predict Severe Maternal Morbidity Based on 33993 Deliveries of Registered Study in China

    Nov 1, 2014, 00:00

  • Is Chinese Syndrome Necessary in the Effectiveness Evaluation of Chinese Herbal Formulas?

    Nov 1, 2014, 00:00

  • HEALTH ECONOMIC EVALUATION OF DIAGNOSTIC AND PROGNOSTIC PREDICTION MODELS. A SYSTEMATIC REVIEW

    Nov 1, 2014, 00:00

  • Development of a Conceptual Model for Pediatric Oncology Results from a Review of Qualitative Research Literature and Clinician Interviews

    Nov 1, 2014, 00:00

  • Symtomatic Factors in Patients With Major Depressive Disorder (MDD)- Results from an Observational Study

    Nov 1, 2014, 00:00

  • Impact of Medication Adherence by Using Indian Version Compliance Questionnaire Rheumatology (Cqr) and Medication Adherence Report Scale (Mars) Tools on Quality of Life of Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Apoptosis and Oxidative Stress Induced By Exposure of Microwave Radiation In Rat Thymus- Modulatory Effect of Melatonin

    Nov 1, 2014, 00:00

  • Correlation of Recent HTA Decisions Between Taiwan and Korea- Implication for Launch Strategies

    Nov 1, 2014, 00:00

  • Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension – Results of a Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Ranolazine For The Treatment Of Angina Pectoris In Russia

    Nov 1, 2014, 00:00

  • Epidemiology and Severity of Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)

    Nov 1, 2014, 00:00

  • Impacts Of Bar-Code Medication Administration (Bcma) On Patients' Safety in Taiwan

    Nov 1, 2014, 00:00

  • Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Carotid Artery Stenting Versus Endarterectomy For Symptomatic Carotid Stenosis Patients

    Nov 1, 2014, 00:00

  • Patient Reported Outcomes(Pros) in Patients with Lower Urinary Track Symptom(Luts)/Benign Prostatic Hyperplasia(Bph) Accompanied with Overactive Bladder(Oab) in Korea

    Nov 1, 2014, 00:00

  • Estimating Means from Medians- A Case Study With Treatments for Metastatic Colorectal Cancer (MCRC)

    Nov 1, 2014, 00:00

  • Self-Reported Frequency and Impact of Non-Severe Hypoglycaemia in Insulin-Treated Adults in the UK

    Nov 1, 2014, 00:00

  • Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practi Insights-Ipf Registry

    Nov 1, 2014, 00:00

  • Feasibility of A Network Meta-Analysis in Endometriosis

    Nov 1, 2014, 00:00

  • The Impact Of Pharmaceutical Policies On Pharmaceutical Sales Patterns In Sweden And Japan

    Nov 1, 2014, 00:00

  • Prevalence-Based Measurement of the Economic Burden of Rare Diseases- Case Review To Determine the Annual Cost of Acromegaly In Italy

    Nov 1, 2014, 00:00

  • Patient, Insuree and Public Participation in Health Technology Assessment- An International Comparison

    Nov 1, 2014, 00:00

  • Psychometric Evaluation Of The Patient's Knee Implant Performance (PKIP) Questionnaire For The Assessment Of Primary Total Knee Arthroplasty

    Nov 1, 2014, 00:00

  • The Patient Experience of Alcohol use Disorder

    Nov 1, 2014, 00:00

  • Possibilities of Breast Cancer Prevention

    Nov 1, 2014, 00:00

  • Hand Hygiene Compliance or the Influencing Factors of Efficiency in the Scope of Students

    Nov 1, 2014, 00:00

  • Complications, costs And Resource Utilization in Real-World Complex Abdominal Wall Reconstruction Patients

    Nov 1, 2014, 00:00

  • Cost-Benefit Model of Varying Nexplanon and Other Long-Acting Reversible Contraceptive (Larc) Methods- Uptake Compared to the Oral Contraceptive Pill- UK Perspective

    Nov 1, 2014, 00:00

  • Cost-Utility of Cancer Therapies – the 'Cost' of Different Utility Generation Strategies

    Nov 1, 2014, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Cerebral Palsy and Other Paralytic Syndromes in Hungary

    Nov 1, 2014, 00:00

  • Anticipated Price Disclosure- Impact on Funding Decisions in Australia

    Nov 1, 2014, 00:00

  • The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies

    Nov 1, 2014, 00:00

  • Survival or Mortality- Framing of the Risk Attribute in a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Upfront Overall Survival Modelling in Comparison to Real World Data- Lenalidomide for the Treatment of Multiple Myeloma Patients in South Korea

    Nov 1, 2014, 00:00

  • Linking Health Care Administrative Databases And National Registry Data In Order To Monitor Icd Therapy In Italy

    Nov 1, 2014, 00:00

  • Economic Comparison of Empirical Versus Diagonstic-Driven Strategies for Immunocompromised Patients with Suspected Fungal Infection Results from a Chinese Payer Perspective

    Nov 1, 2014, 00:00

  • Impact of Vaccination- Health Impact and Cost-Effectiveness to Make Informed Policy Decision on the Introduction of Human Papillomavirus (Hpv) Vaccine to the National Immunization Program (Nip) in Thailand

    Nov 1, 2014, 00:00

  • Long-Term Trends in Breast Cancer Epidemiology in the Slovak Republic

    Nov 1, 2014, 00:00

  • Translation and Validation of Kidney Disease and Quality of Life (Kdqol-Sftm 1.2) Instrument to Measure Health Related Quality of Life Of Indian Patients with Kidney Disease

    Nov 1, 2014, 00:00

  • Efficacy and Hospitalization Length of Stay of Single Dose Oritavancin Compared to 7-10 Days of Vancomycin in Patients with Acute Bacterial Skin and Skin Structure Infections in the Us and Eastern Europe

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Maternal Immunisation for Pertussis in New Zealand

    Nov 1, 2014, 00:00

  • Translation and Linguistic Validation of the Electronic Colombia Suicide Severity Rating Scale in Asia-Pac

    Nov 1, 2014, 00:00

  • The Impact Of Drug Price Control Policy For Diabetes Medication- A Longitudinal Analysis In Taiwan

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Saxagliptin When Added To Metformin And Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus In Spain

    Nov 1, 2014, 00:00

  • Health Care-Associated Infection Prevalence Among Grade a Tertiary Hospitals in China- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Prospective Study on the Average Cost of Therapy for Bronchial Asthma Patients in an Indian Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Population Health- Mental Health of us Veterans by Benefits Enrollment Status

    Nov 1, 2014, 00:00

  • Impact Of International And Therapeutic Referencing On Prices And Launch Optimization

    Nov 1, 2014, 00:00

  • Had the Individual Medical Burden of Basic Health Insurance Participants Really Been Alleviated in 2009-2012?

    Nov 1, 2014, 00:00

  • Global HTA Assessments of Ultra-Orphan Products- A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase)

    Nov 1, 2014, 00:00

  • The Impact of the Information System of Medical Devices in Portugal

    Nov 1, 2014, 00:00

  • Atomoxetine for the Treatment of Newly Diagnosed Adults with Adhd - a Cost Effectiveness Analysis in Spain

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Treatment With Tocilizumab in Russian Children With Systemic Juvenile Idiopathic Arthritis

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Brentuximab Vedotin in Hodgkin Lymphoma in Sweden

    Nov 1, 2014, 00:00

  • Orphan and Rare Diseases - the Payer Perspective

    Nov 1, 2014, 00:00

  • Economic Impact of New Rural Cooperative Medical Scheme In China

    Nov 1, 2014, 00:00

  • Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection

    Nov 1, 2014, 00:00

  • Comparative Effectiveness Study of Enzymatic Replacement Therapies In the Treatment of Gaucherxs Disease On Adults

    Nov 1, 2014, 00:00

  • Potential Cost-Effectiveness Of Therapeutic Drug Monitoring In Patients With Resistant Hypertension

    Nov 1, 2014, 00:00

  • Implementation of International Chart Review Studies- An Assessment of Ethics and Regulatory Considerations

    Nov 1, 2014, 00:00

  • Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

    Nov 1, 2014, 00:00

  • Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in Greece

    Nov 1, 2014, 00:00

  • Forecasting Outpatient Pharmaceutical Expenditure for Cancer Treatment in Germany

    Nov 1, 2014, 00:00

  • Impact of Omalizumab on Poor Asthma Control Events and Medication Utilisation in Patients With Moderate or Severe Persistent Asthma

    Nov 1, 2014, 00:00

  • The Impact of Different Levels of Clinical Pharmacist Interventions on the Therapeutic Plan and Cost Saving

    Nov 1, 2014, 00:00

  • Cost-Minimisation Analysis of Dapagliflozin Compared To Lixisenatide As An Add-On To Insulin In The Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

    Nov 1, 2014, 00:00

  • A Comparison of Market Access Evaluations for new Oncology Therapies in France, Germany and the UK- An Analysis Using the Prismaccess Database

    Nov 1, 2014, 00:00

  • Estimating The Value Of Cangrelor From Eliminating Preloading In Coronary Artery Bypass Graft (Cabg) Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut Guttmann

    Nov 1, 2014, 00:00

  • Analysis on Policies of Biosimilar Market in China

    Nov 1, 2014, 00:00

  • Cost Comparison of Surgical and Non-Surgical Treated Lumbar Spinal Stenosis Patients

    Nov 1, 2014, 00:00

  • Costs Associated with the Use of Enzyme-Inducing Anti-Epileptic Drugs Versus Non-Enzyme-Inducing Anti-Epileptic Drugs- A Systematic Review

    Nov 1, 2014, 00:00

  • Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc)- A Cost Utility Analysis from a Chinese Health Care Perspective

    Nov 1, 2014, 00:00

  • Direct Health Care Costs Associated With Opioid-Induced Constipation

    Nov 1, 2014, 00:00

  • The Burden of Myelofibrosis In Greece

    Nov 1, 2014, 00:00

  • The Relationship Between Masked Hypertension and Obesity

    Nov 1, 2014, 00:00

  • Using The Ispor 2013 European Congress as a Big Data Case Study

    Nov 1, 2014, 00:00

  • Impact of Drug Policy Regulations on the Consumption of Antihypertensive Drugs in Slovakia

    Nov 1, 2014, 00:00

  • Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

    Nov 1, 2014, 00:00

  • The Costs of Major and Minor Cycling Accidents in Tasmania, Australia

    Nov 1, 2014, 00:00

  • Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission Model

    Nov 1, 2014, 00:00

  • Impact of Demographics on Health Preferences in China- An Exploratory Analysis of China EQ-5D-5L Valuation Study

    Nov 1, 2014, 00:00

  • Clinical Effectiveness of Fumaric Acid Esters (Fumaderm) in Psoriasis- A Systematic Review of Literature

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Norway

    Nov 1, 2014, 00:00

  • Innovation May Drive Streamlined Access to New Biopharmaceuticals Across Some Emea Markets

    Nov 1, 2014, 00:00

  • Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests

    Nov 1, 2014, 00:00

  • Adherence to Nice Guidance For Initiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In Primary Care In England And Wales - An Evaluation Using The Clinical Practice Research Datalink (Cprd)

    Nov 1, 2014, 00:00

  • An Efficient Design for Cost-Effectiveness Studies of Personalized Medicine Strategies

    Nov 1, 2014, 00:00

  • The Impact of Treatment of Thyreoid Disease in Pregnant Women to the Outcome of Giving Birth

    Nov 1, 2014, 00:00

  • Validation of the SPHR Diabetes Prevention Model

    Nov 1, 2014, 00:00

  • Literature Review of Decision-Analytical Models Used in the Economic Evaluation of Empirical/Targeted Antifungal Treatments for Invasive Fungal Infections

    Nov 1, 2014, 00:00

  • Burden of Non-Adherence To Type 1 Diabetes Mellitus Therapeutic Guidelines In France

    Nov 1, 2014, 00:00

  • Comparing the Efficacy of Anti-Vascular Endothelia Growth Factor Drugs for Treatment of Age-Related Macular Degeneration- a Clinical Literature Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Effect of A Pharmacy-Based Diabetes Management Program on Glycemic Control in an Inpatient General Medicine Population

    Nov 1, 2014, 00:00

  • Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced Cancer

    Nov 1, 2014, 00:00

  • Price Variation in Obstetrical Services in A Rural State

    Nov 1, 2014, 00:00

  • Incidence and Prevalence of COPD By Gold 2013 Classification in the Netherlands

    Nov 1, 2014, 00:00

  • Health Care Costs in Patients With Type 2 Diabetes in Flanders Based on A Combination of Clinical And Health Insurance Data

    Nov 1, 2014, 00:00

  • Methodological Requirements Regarding Quality of Life Measurement in the Early Assessment of Benefit In Germany

    Nov 1, 2014, 00:00

  • Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders

    Nov 1, 2014, 00:00

  • Application of A Model Of Decision Based on Fuzzy Logic to Pharmacoeconomics- Treatment of CROHN'S Disease With Antitnf in Out of Label Use

    Nov 1, 2014, 00:00

  • Cost Effectiveness Of Solifenacin Compared With Oral Antimuscarinic Agents For The Treatment Of Patients With Overactive Bladder (Oab) In The Uk

    Nov 1, 2014, 00:00

  • Archimedes- A Large Scale Simulation System for Health Care Research and its Applications for Asian Countries

    Nov 1, 2014, 00:00

  • Impact of Allergen Immunotherapy on Quality of Life and Health Care Costs in Adults and Children With Grass Pollen-Induced Allergic Rhinitis in Germany

    Nov 1, 2014, 00:00

  • Carer Perceived Burden as a Predictor of Health-Related Quality of Life- The Case of Colorectal Cancer

    Nov 1, 2014, 00:00

  • Bevacizumab for Metastatic Colorectal Cancer- A Literature Review on Meta-Analyses and Cost-Effectiveness Analyses

    Nov 1, 2014, 00:00

  • Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

    Nov 1, 2014, 00:00

  • Mapping European Database Usage- An Analysis of Published Data Types

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis of Oral Capecitabine and Tegafur for Colorectal Cancer Treatment in Russia

    Nov 1, 2014, 00:00

  • Economic Impact Model of Breast Cancer Treatment at Early Stages in the Mexican Public Health Care Sector

    Nov 1, 2014, 00:00

  • Use of Services and Cost of Agitation and Containment in Psychiatric Hospitals- a Systematic Review

    Nov 1, 2014, 00:00

  • Mast (Minimal Access Spinal Technologies) Versus Open Surgery- Cost Analysis From Hospital Perspective

    Nov 1, 2014, 00:00

  • Hospitalization Burden Among Dialysis Patients In Brazil- an Analysis of The Public Health System Database

    Nov 1, 2014, 00:00

  • State of the Art Research In Austria- Dexhelpp - Decision Support For Health Policy and Planning- Methods, Models and Technologies Based On Existing Health Care Data

    Nov 1, 2014, 00:00

  • Costs of Psoriasis in Europe. A Systematic Review of the Literature

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Biologic Therapies in Russian Patients With Rheumatoid Arthritis and Intolerance or Inadequate Response to Conventional Basic Therap

    Nov 1, 2014, 00:00

  • HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA

    Nov 1, 2014, 00:00

  • To Study the Treatment Pattern and Cost of Illness in Bipolar Disorder Patients in Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Prospective Study on Quality of Life (QOL) of Bronchial Asthma Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Surgical Management of Stress Urinary Incontinence With Single-Incision Mini-Sling Versus Tension-Free Vaginal Obturator in Spain

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness OF Canagliflozin (Cana) Versus Dapagliflozin (Dapa) In Patients With Type 2 Diabetes Mellitus (T2dm) With Inadequate Control On Metformin (Met) Monotherapy In The United Kingdom

    Nov 1, 2014, 00:00

  • Using an Innovative Approach to Build a Prospective Diabetes Cohort Registry of Patients With Type 2 Diabetes in Germany- DIAREG

    Nov 1, 2014, 00:00

  • Proposal for a Comprehensive Definition of Budget Impact Analysis

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Lung Cancer in the Slovak Republic

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Use of Dydrogesterone in Premenstrual Syndrome

    Nov 1, 2014, 00:00

  • Validation of The Hospital Episode Statistics Outpatient Dataset in England

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised Patients

    Nov 1, 2014, 00:00

  • The Burden of Parkinson Disease Amongst Caregivers in Spain Over 4 Years

    Nov 1, 2014, 00:00

  • Implementation and Assessment of Periodic Safety Update Reporting System at Tertiary Care Teaching Hospital, Karnataka, India- A Drug Controller General of India Initiative

    Nov 1, 2014, 00:00

  • Will Governments be Able to Afford a Cancer Cure Under Current Health Economic Evaluation Methods?

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Research and Application In 10 Asian Countries Between 2003 and 2013- A Systematic Review

    Nov 1, 2014, 00:00

  • Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States

    Nov 1, 2014, 00:00

  • Coping With A New Biologic Paradigm- Payer Strategies for the Purchasing of Complex Biosimilars

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)

    Nov 1, 2014, 00:00

  • Setting up the Right Scenarios for Cost-Effectiveness Analysis- An Example with Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients in China

    Nov 1, 2014, 00:00

  • Treating Verse Non-Treating Obsturictive Sleep Apnea in Italy and Fran A Markov Model-Based Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Patient Experience With The Single-Use Pen For Injection of Once Weekly Dulaglutide in Injection-Naive Patients With Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Portugal

    Nov 1, 2014, 00:00

  • What are the Lifelong costs of Vaccinating one Individual? The French Case

    Nov 1, 2014, 00:00

  • Feasibility of Conducting Retrospective Studies Using Hashtags and Social Media Data From Facebook and Twitter

    Nov 1, 2014, 00:00

  • Return on Investment of Preventively Vaccinating Health Care Workers Against Pertussis- A Dutch Case Study

    Nov 1, 2014, 00:00

  • Hypertension Treatment in Chronic Kidney Disease Stage 3, 4 and 5- A Hospital Based Cross-Sectional Study in Malaysia

    Nov 1, 2014, 00:00

  • Price Comparison Between the Essential and Non-Essential Anti-Infective Medicines Among National Reimbursement Drug List in China

    Nov 1, 2014, 00:00

  • Awareness of Breast Cancer and its Prevention. A Comparative Survey Among Finnish and Hungarian Women

    Nov 1, 2014, 00:00

  • Discrete Event Simulation For The Cost-Effectiveness Evaluation Of Pet-Ct Scans In The Diagnosis Of Conn's Disease In Hypertensive Patients

    Nov 1, 2014, 00:00

  • Strategies To Overcome Hurdles In Hta Appraisals Amid Limitations Resulting From Single-Arm Trial Data

    Nov 1, 2014, 00:00

  • A Comparison of International Health Technology Assessment Systems – Does The Perfect System Exist?

    Nov 1, 2014, 00:00

  • Physicians' and Patients' Preferences Over the Attributes of Biological Agents Used In the Treatment of Rheumatic Diseases In Spain- A Conjoint Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00

  • The Clinical Evidence Base of Treatment Options in Alzheimer's Disease- A Systematic Literature Search

    Nov 1, 2014, 00:00

  • Sofosbuvir For The Treatment Of Chronic Hepatitis C- A Comprehensive Cost-Effectiveness Analysis Across Hcv Genotypes, Pretreatment Conditions And Hiv Co-Infection

    Nov 1, 2014, 00:00

  • Review Of Reference Pricing Effects On Pharmaceuticals

    Nov 1, 2014, 00:00

  • Health Insurance Cost of Alzheimer Dementia In Hungary- A Cost of Illness Study

    Nov 1, 2014, 00:00

  • Potential Epidemics of Drugs Resistant Bacteria in Poverty Stricken Countries Like Pakistan

    Nov 1, 2014, 00:00

  • Epidemiology of Patients with Metastatic Castrate Resistant Prostate Cancer in Europe and Australia

    Nov 1, 2014, 00:00

  • The Study on the Prescribing Pattern of Acinetobacter Infection in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Network Meta-Analysis With Baseline Risk Adjustment To Assess The Relative Efficacy Of Ustekinumab In Adult Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Development Of An Influenza Outbreak Forecasting Model Using Time Series Analysis Methods

    Nov 1, 2014, 00:00

  • Medicare Provider Utilization and Payment Data- The Book to Bill Gap

    Nov 1, 2014, 00:00

  • Estimating Costs in A Cost-Effectiveness Analysis- Adherence to HTA Guidance

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Cost-Utility of Granulocyte Colony-Stimulating Factors in the Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in Gree A Comparative Analysis

    Nov 1, 2014, 00:00

  • Assessing Willigness to Pay Among Psoriasis and Psoriatic Arthritis Patients

    Nov 1, 2014, 00:00

  • Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?

    Nov 1, 2014, 00:00

  • Device Handling Errors and the Impact on Quality of Life and Health Care Resource Use in Asthmatic Patients

    Nov 1, 2014, 00:00

  • Economic Evaluation of Alzheimer

    Nov 1, 2014, 00:00

  • Economic Impact of a Genomic Companion Diagnostic Test for Breast Cancer Patients in French Private Hospitals

    Nov 1, 2014, 00:00

  • Logistics of Monitoring of Vitamin K Antagonists in Western European Countries- Prefer in Vte Registry

    Nov 1, 2014, 00:00

  • Outcomes of Patients With Neovascular Age-Related Macular Degeneration (Namd) In Greece Under Ranibizumab

    Nov 1, 2014, 00:00

  • The Prevalence and Cost of Illness in Women With Endometriosis in Ukraine

    Nov 1, 2014, 00:00

  • The Potential of (TARGETED) MR Colonography as a Screening Tool for Colorectal Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia

    Nov 1, 2014, 00:00

  • Direct Costs of Diabetic Foot Ulcers in Russia

    Nov 1, 2014, 00:00

  • Comparing Characteristics of Hungarian “Real Life” Patients With Participants of RCTS- First-Line Disease Modifying Therapies in Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Hepatitis a Vaccination in Indonesia

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan

    Nov 1, 2014, 00:00

  • Mabthera® (Rituximab) for the Treatment of Severe Granulomatosis With Polyangiitis (Gpa) and Microscopic Polyangiitis (Mpa) – A Cost-Utility Model for the United Kingdom

    Nov 1, 2014, 00:00

  • The Epidemiology of Medical Treatment for Glaucoma and Ocular Hypertension in Germany

    Nov 1, 2014, 00:00

  • Pharmacoepidemiology of Cellular/Tissue Derived Products for the Treatment of Venous Leg Ulcers in Outpatient Care Settings

    Nov 1, 2014, 00:00

  • How Iranian People Think About Generic Substitution?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in Dominican Republic, in Patients With Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Biphasic Insulin Aspart In The Treatment Of Type 2 Diabetes Mellitus In Malaysia- A Public Payer Perspective

    Nov 1, 2014, 00:00

  • Health Care Reform in China And The United States- A Tale of Two Nations Seeking To Improve Access To Affordable Coverage

    Nov 1, 2014, 00:00

  • Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium

    Nov 1, 2014, 00:00

  • Uncertainty and Probabilistic Methods in Multi-Criteria Decision Analysis

    Nov 1, 2014, 00:00

  • Health Technology Assessment and Environmental Costs- Time for Health Care To Catch Up?

    Nov 1, 2014, 00:00

  • The Reliability and Validity of the Chinese Version of the Eight-Item Morisky Medication Adherence Scale

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Health-State Utility Values in Breast And Prostate Cancer Measured using the EQ-5D- A Systematic Review of the Literature

    Nov 1, 2014, 00:00

  • Market Access Pathway for Medical Nutrition in Europe and The Us

    Nov 1, 2014, 00:00

  • Drug Utilization Study of Antipsychotics used for the Hospital Treatment Of Schizophrenia in Russia

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of First-Line Regimen Between Cisplatin Plus Pemetrexed and Carboplatin Plus Paclitaxel In Advanced Non-Squamous Non-Small-Cell Lung Cancer in Thailand

    Nov 1, 2014, 00:00

  • Goal Attainment Scaling – A Useful Individualized Clinical Outcome Measure

    Nov 1, 2014, 00:00

  • Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain

    Nov 1, 2014, 00:00

  • Exploring the Usefulness of Social Media and Patient Forums in Identifying indirect Costs of a Disease

    Nov 1, 2014, 00:00

  • Patient Preferences in the Choice of Disease Modifying Anti-Rheumatic Drugs

    Nov 1, 2014, 00:00

  • Oncology Products in the Amnog Process – Learnings for a Successful Dossier Submission

    Nov 1, 2014, 00:00

  • Long-Term Modeling of Using Manually Coded and Autocoded Blood Glucose Meters in Diabetes Treatment

    Nov 1, 2014, 00:00

  • Comparison of Post-Authorisation Measures From Regulatory Authorities With Additional Evidence Requirements From HTA Bodies in Germany

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD)- Cross-Model Comparison of Hypothetical Treatment Scenarios

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) in Sweden

    Nov 1, 2014, 00:00

  • Pattern of Antidepressant Utilization and Cost in Iran From 2007-2011 in Comparison to European and East Asian Countries and Literature Review

    Nov 1, 2014, 00:00

  • Does Blood Lipid Screening is Cost-Effectiveness Among Chinese Adults Aged 45 And Above?

    Nov 1, 2014, 00:00

  • Targeted Literature Review Of Unmet Need In The Hyperlipidaemia Population With High Risk Of Cardiovascular Disease

    Nov 1, 2014, 00:00

  • Economic Impact of the Inclusion of Pertuzumab for the Treatment of Metastatic Breast Cancer HER2 +

    Nov 1, 2014, 00:00

  • COUGH AS A KEY SYMPTOM IN ASTHMA, ALLERGIC RHINITIS, COPD AND RHINOSINUSITIS AND ITS IMPACT IN ASIA

    Nov 1, 2014, 00:00

  • Comparison of Generic, Condition-Specific and Mapped Health State Utility Values for Pediatric Asthma

    Nov 1, 2014, 00:00

  • A Comparison of Modelling Techniques- Patient Simulation Verse Markov Modelling in Ophthalmology

    Nov 1, 2014, 00:00

  • Understanding The Role of Subgroup Analysis And Tests For Homogeneity or Interaction in the Amnog Dossier

    Nov 1, 2014, 00:00

  • Reality in Market Access In Germany and France – Comparative Analysis of Added Benefit Decisions on Innovative Pharmaceutical Therapies

    Nov 1, 2014, 00:00

  • Deterministic Versus Stochastic Prediction of Risk for Cardiovascular Events

    Nov 1, 2014, 00:00

  • The Trend of the Prices Of New Marketed Drugs in Turkey

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Analysis for Hiv Treatment Alternatives in Turkey

    Nov 1, 2014, 00:00

  • Systematic Review of Economic Evaluation of Health Technologies Developed In Brazil From 1980-2013

    Nov 1, 2014, 00:00

  • Comparative Study On Health Related Quality Of Life Of Farmers And Workers

    Nov 1, 2014, 00:00

  • Different Strategies for Latent TB Assessment in Patients Undergoing Anti-TNF Treatment- an Economic Model

    Nov 1, 2014, 00:00

  • A Systematic Literature Review of the Humanistic Burden of Multiple Myeloma

    Nov 1, 2014, 00:00

  • Predicted Versus Actual Budget Impact of High-Cost Drugs In Ireland

    Nov 1, 2014, 00:00

  • The Impact Of Cardiovascular Disease And Type 2 Diabetes Mellitus On Social Cost In Chronic Kidney Disease Patients In Italy

    Nov 1, 2014, 00:00

  • Alzheimer's Disease Caregiver Burden in Japan and the 5 E.U

    Nov 1, 2014, 00:00

  • Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study

    Nov 1, 2014, 00:00

  • The Cost Of Illness Of Atrial Fibrillation In Italy- A Cohort Of Hospitalized Patients

    Nov 1, 2014, 00:00

  • Feasibility of Pharmacoeconomic Evaluations of Traditional Chinese Medicine from the Perspectives of the Health Insurance Review Assessment Service in South Korea

    Nov 1, 2014, 00:00

  • The Effect of Dietary Selenium Intake in The Gene Expression of P38, P65, and Caspase-3 in Fluorosis Patients

    Nov 1, 2014, 00:00

  • What Is The Proportion of Patients Who Return Counter Referral Slips to the Original Referral Service For Confirmation of Arrival to the Hospital?

    Nov 1, 2014, 00:00

  • The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure

    Nov 1, 2014, 00:00

  • Content Analysis And Effectiveness Of Interventions To Enhance Oral Antidiabetic Drug (Oad) Adherence In Adults With Type 2 Diabetes- A Systematic Review And Meta-Analysis

    Nov 1, 2014, 00:00

  • Tadalafil in Benign Prostatic Hyperplasia- Protocol for the Systematic Review of Adverse Events

    Nov 1, 2014, 00:00

  • The Budget Impact of Using Fidaxomicin for Hospitalised Cdi Patients from the Danish Health Care Perspective

    Nov 1, 2014, 00:00

  • The Proportional Odds Model Is More Efficient Than The Multinomial Logistic Model For Network Meta-Analyses Of Ordered Outcomes

    Nov 1, 2014, 00:00

  • Network Meta-Analysis of the Relative Efficacy of Pharmacological and Psychological Interventions in Adults with Obsessive Compulsive Disorder

    Nov 1, 2014, 00:00

  • Cardiovascular Risk, Gender And Medication Adherence In Rural Area Of Vietnam

    Nov 1, 2014, 00:00

  • Burden Of Disease Analysis Of Ankylosing Spondylitis In Hungary

    Nov 1, 2014, 00:00

  • Applicability Of Eunethta Relative Effectiveness Assessment of Pazopanib For National Assessments

    Nov 1, 2014, 00:00

  • Treatment Continuation and Treatment Characteristics of 3 Long Acting Antipsychotic Medications (Paliperidone Palmitate, Risperidone Microspheres and Haloperidol Decanoate) in Belgium

    Nov 1, 2014, 00:00

  • Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts

    Nov 1, 2014, 00:00

  • To What Extent Do Disease and Treatment Characteristics Influence Hta-Based Recommendations for A Sample of Orphan Drugs In Three Countries, and Could These Indicate Whether Orphan Drugs Have A “Special Status”?

    Nov 1, 2014, 00:00

  • Future Impact of Dementia on the Caregiver in China

    Nov 1, 2014, 00:00

  • First Experiences With The New Testing Examination and Treatment- Methods in Germany- Is This A New Amnog Clone?

    Nov 1, 2014, 00:00

  • Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe- Optimising Market Access in Increasingly Challenging Markets

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa ...

    Nov 1, 2014, 00:00

  • A Systematic Review and Network Meta-Analysis of Pharmacological Therapies Used for Patients with Advanced Parkinson's Disease

    Nov 1, 2014, 00:00

  • Catastrophic Health Expenditures and Chronic Condition Patients in Greece

    Nov 1, 2014, 00:00

  • Incidence-Based Cost of Asthma in Vietnam

    Nov 1, 2014, 00:00

  • Treating to the Target of Das28 2.6 in Rheumatoid Arthritis- the Impact of Efficacy on Cost Effectiveness

    Nov 1, 2014, 00:00

  • Study of Technical Conditions for Improvement of Angiographic Image Quality

    Nov 1, 2014, 00:00

  • Treatment Plan Comparison- An Observational Study of the Marche Region

    Nov 1, 2014, 00:00

  • Primary care physicians in an interferon-free world- could safer, more efective oral hepatitis c therapies lead to improved outcomes through education and pcp-prescribed treatment?

    Nov 1, 2014, 00:00

  • Physicians As Double Agents In A Universal Health Care System- Evidence From Generic Pharmaceutical Adoption In Taiwan

    Nov 1, 2014, 00:00

  • Organization Potency and Human Resource

    Nov 1, 2014, 00:00

  • The Budget Impact Of New Generation Ct Scanners For Difficult-To-Image, Low-Risk Patients With Suspected Cad

    Nov 1, 2014, 00:00

  • Efficacy Of Add – On Vildagliptin Therapy To Metformin For Type Ii Diabetes Mellitus Patients In South Indian Resource Limited Settings – Pilot Study

    Nov 1, 2014, 00:00

  • Social Media Meets Population Health- A Sentiment And Demographic Analysis of Tobacco and E-Cigarette Use Across The “Twittersphere”

    Nov 1, 2014, 00:00

  • What's the optimal visual inspection screening intervals for cervical cancer screening in real practice of rural china? A cost-utility modeling study

    Nov 1, 2014, 00:00

  • Annual Health Insurance Cost of Breast Cancer Treatment in Hungary

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Bevacizumab- Paclitaxel-Carboplatin (PC) Versus PC in First-Line Therapy of Advanced Non-Small Cell Lung Cancer from Patients' Perspective in Vietnam

    Nov 1, 2014, 00:00

  • Malnutrition in Institutionalized and Community-Dwelling Older Adults in Spain- Estimates of Its Costs To the National Health System

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)

    Nov 1, 2014, 00:00

  • Dapagliflozin (Forxiga®) Versus Glipizide As Add-On Therapies In Type 2 Diabetes Mellitus (T2dm); An Update of The Cost-Effectiveness Based On Long-Term Clinical Evidence From Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • The Burden of Primary Generalized Tonic-Clonic Seizures in Europe and the United States- An Analysis of The National Health and Wellness Survey

    Nov 1, 2014, 00:00

  • Literature Review Of Pro Measures Assessing Anticoagulant Therapy

    Nov 1, 2014, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106 (current)
  • 107
  • 108
  • 109
  • 110
  • »